We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

ACCURAY

Accuray is a radiation oncology company that develops, manufactures and sells tumor treatment solutions. Its solution... read more Featured Products: More products

Download Mobile App




TomoTherapy Systems Used to Treat First Patients in Algeria

By MedImaging International staff writers
Posted on 18 Apr 2017
Image: The TomoTherapy system for precision radiation therapy treatment of cancer patients (Photo courtesy of Accuray).
Image: The TomoTherapy system for precision radiation therapy treatment of cancer patients (Photo courtesy of Accuray).
Two TomoTherapy systems installed in Algeria, the first systems in the Africa continent, have begun treating cancer patients.

The advanced radiation treatments that can provide extremely precise treatments for a wide range of cancers are installed in a new radiotherapy and medical oncology center in Sidi Abdellah, in Algeria.

Accuray installed the TomoTherapy Systems at the Radiotherapy and Medical Oncology Center (Sidi Abdellah, Algiers, Algeria). The center has also purchased a third TomoTherapy System, and an Accuray CyberKnife M6 System that will be installed by the end of 2018.

The TomoTherapy System is based on a Computed Tomography (CT) platform and can provide accurate 360-degrees radiation delivery, or use clinician-specified beam angles, and daily 3D image guidance. The system provides standard radiation therapy for breast, prostate, head and neck, and lung cancers, as well as total marrow irradiation.

Corporate SVP and President of Worldwide Commercial Operations at Accuray, Lionel Hadjadjeba, MD, said, "We are honored that the Radiotherapy and Medical Oncology Center team has selected the Accuray systems to expand their cancer treatment options. Their decision reinforces growing global recognition of the importance of radiation therapy in treating cancer. The TomoTherapy and CyberKnife Systems provide an optimal combination of efficacy and safety while minimizing the impact of treatment on daily lives, and will enable the clinical team to confidently provide each cancer patient with a treatment program that addresses his or her individual needs."

Digital Color Doppler Ultrasound System
MS22Plus
Ultrasound Needle Guidance System
SonoSite L25
Digital X-Ray Detector Panel
Acuity G4
Adjustable Mobile Barrier
M-458

Channels

Nuclear Medicine

view channel
Image: The new tracer, 64Cu-NOTA-EV-F(ab′)2​, targets nectin-4, a protein strongly linked to tumor growth in both TNBC and UBC cancer types. (Wenpeng Huang et al., DOI: 10.2967/jnumed.125.270132)

PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers

Triple-negative breast cancer (TNBC) and urothelial bladder carcinoma (UBC) are aggressive cancers often diagnosed at advanced stages, leaving limited time for effective treatment decisions.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.